Publisher Correction: Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia

By sjmartinez • June 7, 2024

Koeberl D, Schulze A, Sondheimer N, Lipshutz GS, Geberhiwot T, Li L, Saini R, Luo J, Sikirica V, Jin L, Liang M, Leuchars M, Grunewald S. Publisher Correction: Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia. Nature. 2024 Jun 6. doi: 10.1038/s41586-024-07646-z. Epub ahead of print. Erratum for: Nature. 2024 Apr;628(8009):872-877. doi: 10.1038/s41586-024-07266-7. PMID: 38844679.

Tags: Endocrinology, Publications

Related Posts

Oxidative stress-regulatory role of miR-10b-5p in the diabetic human cornea revealed through integrated multi-omics analysis

Zha D, Gamez J, Ebrahimi SM, Wang Y, Verma N, Poe AJ, White S, Shah R, Kramerov AA, Sawant OB, Santiskulvong C, Stotland AB, Wang[...]

The gut microbiome promotes mitochondrial respiration in the brain of a Parkinson’s disease mouse model

Morais LH, Stiles L, Freeman M, Oguienko AD, Hoang JD, Ji J, Jones J, Quan B, Devine J, Bois JS, Chou TF, Trinh J, Picard[...]

Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors

Zhu L, Cheung YM, Chiang C, Gallagher EJ, Hamnvik OR, Mammen J, Quandt Z, Jones R, McDunn J, Al-Bahadili H, Angell T, Bancos I, Betof[...]